Gene therapy and solid-organ transplantation

Enver Akalin, Jonathan S. Bromberg

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Recent developments in transplantation medicine improved the short- and long-term survival of solid-organ transplantation. However, chronic allograft rejection, the side effects of the long-term immunosuppressive treatment, and organ shortage are still the major obstacles to achieving long-term survival. Gene therapy has the potential to meet these challenges and has unique advantages in transplantation. In this review we summarize the studies using gene therapy in solid-organ transplantation.

Original languageEnglish (US)
JournalKidney International
Volume61
Issue numberSUPPL. 1
StatePublished - 2002
Externally publishedYes

Fingerprint

Organ Transplantation
Genetic Therapy
Transplantation
Immunosuppressive Agents
Allografts
Medicine
Therapeutics

Keywords

  • Allograft
  • Gene therapy
  • Rejection
  • Transplantation
  • Xenotransplantation

ASJC Scopus subject areas

  • Nephrology

Cite this

Gene therapy and solid-organ transplantation. / Akalin, Enver; Bromberg, Jonathan S.

In: Kidney International, Vol. 61, No. SUPPL. 1, 2002.

Research output: Contribution to journalArticle

Akalin, E & Bromberg, JS 2002, 'Gene therapy and solid-organ transplantation', Kidney International, vol. 61, no. SUPPL. 1.
Akalin, Enver ; Bromberg, Jonathan S. / Gene therapy and solid-organ transplantation. In: Kidney International. 2002 ; Vol. 61, No. SUPPL. 1.
@article{dafe0c97ae4940c2a7f1f6a31fab2aac,
title = "Gene therapy and solid-organ transplantation",
abstract = "Recent developments in transplantation medicine improved the short- and long-term survival of solid-organ transplantation. However, chronic allograft rejection, the side effects of the long-term immunosuppressive treatment, and organ shortage are still the major obstacles to achieving long-term survival. Gene therapy has the potential to meet these challenges and has unique advantages in transplantation. In this review we summarize the studies using gene therapy in solid-organ transplantation.",
keywords = "Allograft, Gene therapy, Rejection, Transplantation, Xenotransplantation",
author = "Enver Akalin and Bromberg, {Jonathan S.}",
year = "2002",
language = "English (US)",
volume = "61",
journal = "Kidney International",
issn = "0085-2538",
publisher = "Nature Publishing Group",
number = "SUPPL. 1",

}

TY - JOUR

T1 - Gene therapy and solid-organ transplantation

AU - Akalin, Enver

AU - Bromberg, Jonathan S.

PY - 2002

Y1 - 2002

N2 - Recent developments in transplantation medicine improved the short- and long-term survival of solid-organ transplantation. However, chronic allograft rejection, the side effects of the long-term immunosuppressive treatment, and organ shortage are still the major obstacles to achieving long-term survival. Gene therapy has the potential to meet these challenges and has unique advantages in transplantation. In this review we summarize the studies using gene therapy in solid-organ transplantation.

AB - Recent developments in transplantation medicine improved the short- and long-term survival of solid-organ transplantation. However, chronic allograft rejection, the side effects of the long-term immunosuppressive treatment, and organ shortage are still the major obstacles to achieving long-term survival. Gene therapy has the potential to meet these challenges and has unique advantages in transplantation. In this review we summarize the studies using gene therapy in solid-organ transplantation.

KW - Allograft

KW - Gene therapy

KW - Rejection

KW - Transplantation

KW - Xenotransplantation

UR - http://www.scopus.com/inward/record.url?scp=0036175802&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036175802&partnerID=8YFLogxK

M3 - Article

VL - 61

JO - Kidney International

JF - Kidney International

SN - 0085-2538

IS - SUPPL. 1

ER -